Nuveen Asset Management, LLC Global Blood Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $1.97 Million - $4.14 Million	-60,744 Reduced 9.34%	589,525 $40.1 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $8.2 Million - $13.8 Million	367,895 Added 130.29%	650,269 $20.8 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $38,776 - $53,740	1,510 Added 0.54%	282,374 $9.08 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $2.07 Million - $3.35 Million	83,125 Added 42.04%	280,864 $7.44 Million
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $4.44 Million - $6.5 Million	-174,174 Reduced 46.83%	197,739 $5.54 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $5.87 Million - $7.86 Million	-180,921 Reduced 32.73%	371,913 $13 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $5.32 Million - $6.95 Million	-136,664 Reduced 19.82%	552,834 $22.5 Million
Q4 2020 May 17, 2021	BUY	$37.65 - $63.77 $3.12 Million - $5.29 Million	82,983 Added 13.68%	689,498 $29.9 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $8.52 Million - $14.4 Million	226,306 Added 59.52%	606,515 $26.3 Million
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $9.61 Million - $13.6 Million	182,224 Added 92.04%	380,209 $21 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $3.82 Million - $6.41 Million	-78,377 Reduced 28.36%	197,985 $12.5 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $754,172 - $1.58 Million	18,077 Added 7.0%	276,362 $14.1 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $10.8 Million - $19.4 Million	-237,320 Reduced 47.88%	258,285 $20.5 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $12.5 Million - $16 Million	276,402 Added 126.09%	495,605 $24 Million
Q2 2019 Aug 15, 2019	BUY	$52.6 - $63.29 $11.5 Million - $13.9 Million	219,203 New	219,203 $11.5 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account